The effects of CPAP withdrawal in patients with OSA on hypoxia-induced markers

Christopher Turnbull (Oxford, United Kingdom), Christopher Turnbull, Peter Santer, Esther Schwarz, Valentina Rossi, Malcolm Kohler, John Stradling, Nayia Petousi

Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Session: Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Session type: Poster Discussion
Number: 2072
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Christopher Turnbull (Oxford, United Kingdom), Christopher Turnbull, Peter Santer, Esther Schwarz, Valentina Rossi, Malcolm Kohler, John Stradling, Nayia Petousi. The effects of CPAP withdrawal in patients with OSA on hypoxia-induced markers. Eur Respir J 2016; 48: Suppl. 60, 2072

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The effect of continuous positive airway pressure on basal metabolism rate in patients with severe obstructive sleep apnea syndrome
Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing
Year: 2015



The effect of positive airway pressure therapy on neurocognitive functions, depression and anxiety in obesity hypoventilation syndrome
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016


The effect of BPAP therapy on basal metabolism rate in patients with obesity hypoventilation syndrome
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies
Year: 2015

Effects of CPAP on albumin redox state and heart rate variability in OSA patients
Source: Annual Congress 2013 –Sleep disordered breathing in special situations II
Year: 2013


The positive effect of CPAP therapy on the level of liver enzymes in obstructive sleep apnea patients
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015

Effect of CPAP treatment on endothelial function, inflammatory markers, blood pressure and glucose control in male and female patients with OSAS
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014

Effects of co-existing asthma and OSA on objectively measured sleep and systemic inflammation
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015


Effects of continuous positive airway pressure therapy in patients with severe obstructive sleep apnea and endothelial dysfunction on 24-hour blood pressure profile
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015


Cognitive function was improved after continuous positive airway pressure treatment in obstructive sleep apnea syndrome
Source: International Congress 2016 – Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea
Year: 2016


The association between hypertension and neutrophil to lymphocyte ratio in patients with obstructive sleep apnea syndrome
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016

Cardiovascular risk markers in patients with OSA. Effects of CPAP treatment
Source: Annual Congress 2012 - Sleep apnoea: clinical topics
Year: 2012


Long term effects of compliance with positive airway pressure (PAP) therapy in patients with obesity hypoventilation syndrome (OHS)
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016

OSAS and oxidative stress before and after treatment with CPAP therapy: Follow-up of 10 patients
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014

Alteration of inflammatory mediators in patients with obstructive sleep apnea
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013


Metabolic syndrome, systemic inflammation and oxidative stress in patients with severe obstructive sleep apnea: effects of CPAP
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008


The role of compliance with positive airway pressure use on blood pressure in patients with obstructive sleep apnea: Is longer use a key-factor?
Source: International Congress 2015 – Paediatric and adult sleep-disordered breathing: from inflammation to treatment and telemedicine
Year: 2015


Sleep apnoea and systemic hypertension
Source: Eur Respir Mon 2010; 50: 150-173
Year: 2010


Complete blood count alterations after 6 months of continuous positive airway pressure treatment in patients with severe obstructive sleep apnea
Source: Annual Congress 2013 –Sleep disordered breathing in special situations I
Year: 2013


Endothelial and systemic inflammation in obstructive sleep apnea syndrome: Impact of CPAP therapy on CRP plasma levels
Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea
Year: 2010


Impact of continuous positive airway pressure on liver injury induced by obstructive sleep apnea: Data from randomized controlled trials
Source: International Congress 2015 – A bout de souffle: hypoxia and sleep-disordered breathing
Year: 2015